[Federal Register Volume 63, Number 145 (Wednesday, July 29, 1998)]
[Notices]
[Page 40543]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20177]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Registration
By Notice dated January 27, 998, and published in the Federal
Register on February 14, 1998, (63 FR 18227), Celgene Corporation, 7
Powder Horn Drive, Warren, New Jersey 07059 made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as a bulk
of manufacturer of the basic classes of controlled substances listed
below
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
2,5-Dimethoxyamphatamine (7396)............ I
4-Methoxyamphetamine (7411)................ I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
------------------------------------------------------------------------
The firm plans to manufacture amphetamine for distribution of the
bulk active substances to its customers, 4-methoxyamphetamine as an
intermediate in the manufacture of a non-controlled substance,
methylphenidate for product research and development and 2,5-
dimethoxyamphetamine to develop, manufacture and sell compounds to
pharmaceutical and agrochemical industries.
DEA has considered the factors in Title 21, United States Code,
Section 823(a) and determined that the registration of Celgene
Corporation to manufacture the listed controlled substances is
consistent with the public interest at this time. Therefore, pursuant
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant
Administrator, Office of Diversion Control, hereby orders that the
application submitted by the above firm for registration as a bulk
manufacturer of the basic classes of controlled substances listed above
is granted.
Dated: July 13, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 98-20177 Filed 7-28-98; 8:45 am]
BILLING CODE 4410-09-M